We all want a solution, and fast. But touting 'old' drugs as a potential COVID-19 treatment comes at a cost. An opinion piece by Professor Eric Morand, Head of School of Clinical Sciences at Monash Health published in The Age highlights the dangers of the recent shortages of hydroxychloroquine and chloroquine, and what it means for patients with autoimmune disease such as lupus.

Read full story here